iSTAR医疗的MINIject 装置有效治疗青光眼,在五年内将眼压降低38%。 iSTAR Medical's MINIject® device effectively treats glaucoma, reducing eye pressure by 38% over five years.

iSTAR医学的MINIjecti装置显示,在五年内对青光眼进行治疗的长期效果显著,将内心压力减少38%。 iSTAR Medical's MINIject® device showed significant long-term effectiveness in treating glaucoma over five years, reducing intraocular pressure by 38%. 审判具有有利的安全特征,没有发生严重不良事件,并显示32%的病人仍然没有药物。 The trial had a favorable safety profile with no serious adverse events and showed that 32% of patients remained medication-free. 该装置已植入全世界5 000多名患者,并正在欧洲和其他全球区域进一步推广。 The device has been implanted in over 5,000 patients worldwide and is being rolled out further in Europe and other global regions.